We are proud to announce that Cellis, a company run by our Director of the Cellular Immunotherapy Center, Prof. Magdalena Król, has received two prestigious grants under the “SMART Path” initiative from the European Funds for Modern Economy (FENG) 2021-2027.

The total cost of the projects amounts to PLN 71,114,187.80, of which over 54% is FENG funding – almost EUR 16.5 million!

Cellular therapy for pancreatic cancer
Grant No. FENG.01.01-IP.01-A0L3/24

Innovative cellular therapy for head and neck cancers
Grant No. FENG.01.01-IP.01-A0L0/24

This support will enable us to further develop our groundbreaking MDC-735 therapy, pushing the boundaries of cell therapies and giving new hope to patients around the world.

We are committed to using these resources responsibly, supporting innovation and fulfilling our mission to revolutionize cancer treatment.

Heartfelt thanks to our wonderful team, partners and FENG for their trust. Together we are shaping the future of oncology.

Published 28.11.2024